These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 9972967

  • 1. Anti-DNA and anti-nucleosome antibody affinity--a mirror image of lupus nephritis?
    Williams RC, Malone C, Blood B, Silvestris F.
    J Rheumatol; 1999 Feb; 26(2):331-46. PubMed ID: 9972967
    [Abstract] [Full Text] [Related]

  • 2. Active systemic lupus erythematosus is associated with depletion of the natural generic anti-idiotype (anti-F(ab')2) system.
    Williams RC, Malone CC, Huffman GR, Silvestris F, Croker BP, Ayoub EM, Massengill S.
    J Rheumatol; 1995 Jun; 22(6):1075-85. PubMed ID: 7674233
    [Abstract] [Full Text] [Related]

  • 3. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
    Williams RC, Malone CC, Meyers C, Decker P, Muller S.
    J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies.
    Gutiérrez-Adrianzén OA, Koutouzov S, Mota RM, das Chagas Medeiros MM, Bach JF, de Holanda Campos H.
    J Rheumatol; 2006 Aug; 33(8):1538-44. PubMed ID: 16783863
    [Abstract] [Full Text] [Related]

  • 5. Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis.
    Grootscholten C, van Bruggen MC, van der Pijl JW, de Jong EM, Ligtenberg G, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
    Arthritis Rheum; 2003 May; 48(5):1355-62. PubMed ID: 12746908
    [Abstract] [Full Text] [Related]

  • 6. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC.
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [Abstract] [Full Text] [Related]

  • 7. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD, Patwardhan MM, Ghosh K.
    Indian J Dermatol Venereol Leprol; 2010 Jan; 76(2):145-9. PubMed ID: 20228543
    [Abstract] [Full Text] [Related]

  • 8. Autoimmunity against nucleosomes and lupus nephritis.
    Van Bruggen MC, Kramers C, Berden JH.
    Ann Med Interne (Paris); 1996 Jan; 147(7):485-9. PubMed ID: 9092359
    [Abstract] [Full Text] [Related]

  • 9. [Role of the nucleosome in the physiopathology of systemic lupus erythematosus].
    Amoura Z, Piette JC.
    Ann Med Interne (Paris); 2003 Feb; 154(1):25-32. PubMed ID: 12746656
    [Abstract] [Full Text] [Related]

  • 10. Are the clonotypes of serum IgG anti-DNA antibodies associated with lupus nephritis in humans?
    Hatakeyama A, Sasaki T, Muryoi T, Murai C, Yoshinaga K.
    J Clin Lab Immunol; 1990 Feb; 31(2):93-7. PubMed ID: 1966991
    [Abstract] [Full Text] [Related]

  • 11. Anti-(DNA-histone) antibodies in active lupus nephritis.
    Suenaga R, Abdou NI.
    J Rheumatol; 1996 Feb; 23(2):279-84. PubMed ID: 8882032
    [Abstract] [Full Text] [Related]

  • 12. Autoantibodies in lupus nephritis patients requiring renal transplantation.
    Stinton LM, Barr SG, Tibbles LA, Yilmaz S, Sar A, Benedikttson H, Fritzler MJ.
    Lupus; 2007 Feb; 16(6):394-400. PubMed ID: 17664229
    [Abstract] [Full Text] [Related]

  • 13. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
    Suleiman S, Kamaliah D, Nadeem A, Naing NN, Che Maraina CH.
    Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
    [Abstract] [Full Text] [Related]

  • 14. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M.
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [Abstract] [Full Text] [Related]

  • 15. Natural autoantibodies in systemic lupus erythematosus.
    Matsiota P, Druet P, Dosquet P, Guilbert B, Avrameas S.
    Clin Exp Immunol; 1987 Jul; 69(1):79-88. PubMed ID: 3498588
    [Abstract] [Full Text] [Related]

  • 16. [Immunology in medical practice. III. Disseminated lupus erythematosus: disturbed apoptosis?].
    Berden JH.
    Ned Tijdschr Geneeskd; 1997 Sep 27; 141(39):1848-54. PubMed ID: 9545742
    [Abstract] [Full Text] [Related]

  • 17. Exposure of chromatin and not high affinity for dsDNA determines the nephritogenic impact of anti-dsDNA antibodies in (NZBxNZW)F1 mice.
    Mjelle JE, Kalaaji M, Rekvig OP.
    Autoimmunity; 2009 Feb 27; 42(2):104-11. PubMed ID: 19005880
    [Abstract] [Full Text] [Related]

  • 18. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus.
    Suzuki N, Harada T, Mizushima Y, Sakane T.
    J Immunol; 1993 Jul 15; 151(2):1128-36. PubMed ID: 8335894
    [Abstract] [Full Text] [Related]

  • 19. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Mar 15; 64(3):444-8. PubMed ID: 15286009
    [Abstract] [Full Text] [Related]

  • 20. Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?
    Mason LJ, Ravirajan CT, Rahman A, Putterman C, Isenberg DA.
    Arthritis Rheum; 2004 Mar 15; 50(3):866-70. PubMed ID: 15022329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.